Literature DB >> 1317290

Basic fibroblast growth factor stimulates the sustained proliferation of mouse epidermal melanoblasts in a serum-free medium in the presence of dibutyryl cyclic AMP and keratinocytes.

T Hirobe1.   

Abstract

Basic fibroblast growth factor (bFGF) stimulated the sustained proliferation of mouse epidermal melanoblasts derived from epidermal cell suspensions in a serum-free medium supplemented with dibutyryl adenosine 3',5'-cyclic monophosphate (DBcAMP). The melanoblasts could be subcultured in the serum-free medium supplemented with the two factors in the presence of keratinocytes, but not in the absence of keratinocytes. In these conditions, some melanoblasts proliferated without differentiating for more than 20 days including a subculture. This is the first report of a successful culture of melanoblasts from mammalian skin. This culture system is expected to clarify further markers for melanoblasts and requirements for their proliferation and differentiation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1317290     DOI: 10.1242/dev.114.2.435

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  11 in total

1.  Loss of nuclear receptor RXRα in epidermal keratinocytes promotes the formation of Cdk4-activated invasive melanomas.

Authors:  Stephen Hyter; Gaurav Bajaj; Xiaobo Liang; Mariano Barbacid; Gitali Ganguli-Indra; Arup Kumar Indra
Journal:  Pigment Cell Melanoma Res       Date:  2010-07-09       Impact factor: 4.693

2.  The murine misty mutation: phenotypic effects on melanocytes, platelets and brown fat.

Authors:  E V Sviderskaya; E K Novak; R T Swank; D C Bennett
Journal:  Genetics       Date:  1998-01       Impact factor: 4.562

3.  The chemokine SDF-1/CXCL12 regulates the migration of melanocyte progenitors in mouse hair follicles.

Authors:  Abdelhak Belmadani; Hosung Jung; Dongjun Ren; Richard J Miller
Journal:  Differentiation       Date:  2008-12-25       Impact factor: 3.880

4.  Survival of 3T3 cells expressing or co-expressing bFGF and/or IGF-I and/or IGF-II in low serum and serum free media.

Authors:  D Li; S Hettle; J McLean; C Macdonald
Journal:  Cytotechnology       Date:  2000-03       Impact factor: 2.058

5.  Effects of low-dose heavy ions on embryonic development in mice and on melanocyte differentiation in the epidermis and hair bulb.

Authors:  Tomohisa Hirobe; Kiyomi Eguchi-Kasai; Kimihiko Sugaya; Masahiro Murakami
Journal:  J Radiat Res       Date:  2012-12-09       Impact factor: 2.724

6.  In vitro dedifferentiation of melanocytes from adult epidermis.

Authors:  Bernadett Kormos; Nóra Belso; Attila Bebes; Gábor Szabad; Sarolta Bacsa; Márta Széll; Lajos Kemény; Zsuzsanna Bata-Csörgo
Journal:  PLoS One       Date:  2011-02-23       Impact factor: 3.240

7.  Investigation of the Anti-Melanogenic and Antioxidant Characteristics of Eucalyptus camaldulensis Flower Essential Oil and Determination of Its Chemical Composition.

Authors:  Huey-Chun Huang; Ya-Chi Ho; Jia-Min Lim; Tzu-Yun Chang; Chen-Lung Ho; Tsong-Min Chang
Journal:  Int J Mol Sci       Date:  2015-05-07       Impact factor: 5.923

8.  Functional neurons and melanocytes induced from immortal lines of postnatal neural crest-like stem cells.

Authors:  Elena V Sviderskaya; David J Easty; Mark A Lawrence; Daniel P Sánchez; Yuri A Negulyaev; Ricken H Patel; Praveen Anand; Yuri E Korchev; Dorothy C Bennett
Journal:  FASEB J       Date:  2009-05-15       Impact factor: 5.191

9.  Supercritical fluid extract of Lycium chinense Miller root inhibition of melanin production and its potential mechanisms of action.

Authors:  Huey-Chun Huang; Wen-Ying Huang; Tsang-Chi Tsai; Wan-Yu Hsieh; Wang-Ping Ko; Kuei-Jen Chang; Tsong-Min Chang
Journal:  BMC Complement Altern Med       Date:  2014-06-28       Impact factor: 3.659

10.  Supercritical Fluid Extract of Spent Coffee Grounds Attenuates Melanogenesis through Downregulation of the PKA, PI3K/Akt, and MAPK Signaling Pathways.

Authors:  Huey-Chun Huang; Chien-Mei Wei; Jen-Hung Siao; Tsang-Chi Tsai; Wang-Ping Ko; Kuei-Jen Chang; Choon-Hoon Hii; Tsong-Min Chang
Journal:  Evid Based Complement Alternat Med       Date:  2016-06-07       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.